LONDON: The collapse of an US$8bil (RM34bil) biotech acquisition and a slump in the Swedish krona left Barclays Plc with a major loss last month.
The London-based bank lost about US$100mil (RM421mil) on currency hedges after the United States private equity firm Advent International and Singapore’s sovereign wealth fund GIC withdrew their bid for Swedish Orphan Biovitrum (Sobi) AB in December, people with knowledge of the matter said.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!